These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38443542)

  • 21. Metformin and risk of age-related macular degeneration in individuals with type 2 diabetes: a retrospective cohort study.
    Gokhale KM; Adderley NJ; Subramanian A; Lee WH; Han D; Coker J; Braithwaite T; Denniston AK; Keane PA; Nirantharakumar K
    Br J Ophthalmol; 2023 Jul; 107(7):980-986. PubMed ID: 35115301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of metformin and development of dry age-related macular degeneration in a U.S. insurance claims database.
    Eton EA; Wubben TJ; Besirli CG; Hua P; McGeehan B; VanderBeek BL
    Eur J Ophthalmol; 2022 Jan; 32(1):417-423. PubMed ID: 33607930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy of age-related macular degeneration.
    Ahmadi MA; Lim JI
    Expert Opin Pharmacother; 2008 Dec; 9(17):3045-52. PubMed ID: 19006477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-related macular degeneration: vision challenge of old age.
    Wang F; Sun X
    Chin Med J (Engl); 2014; 127(8):1405-6. PubMed ID: 24762578
    [No Abstract]   [Full Text] [Related]  

  • 25. Association of lipid-lowering drugs and antidiabetic drugs with age-related macular degeneration: a meta-analysis in Europeans.
    Mauschitz MM; Verzijden T; Schuster AK; Elbaz H; Pfeiffer N; Khawaja A; Luben RN; Foster PJ; Rauscher FG; Wirkner K; Kirsten T; Jonas JB; Bikbov MM; Hogg R; Peto T; Cougnard-Grégoire A; Bertelsen G; Erke MG; Topouzis F; Giannoulis DA; Brandl C; Heid IM; Creuzot-Garcher CP; Gabrielle PH; Hense HW; Pauleikhoff D; Barreto P; Coimbra R; Piermarocchi S; Daien V; Holz FG; Delcourt C; Finger RP;
    Br J Ophthalmol; 2023 Nov; 107(12):1880-1886. PubMed ID: 36344262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between Oral Metformin Use and the Development of Age-Related Macular Degeneration in Diabetic Patients: A Systematic Review and Meta-Analysis.
    Liang KH; Chen CH; Tsai HR; Chang CY; Chen TL; Hsu WC
    Invest Ophthalmol Vis Sci; 2022 Dec; 63(13):10. PubMed ID: 36484633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of metformin against tuberculosis in diabetic patients.
    Sekhar MS; Unnikrishnan MK; Vyas N
    J Infect Public Health; 2017; 10(2):242-243. PubMed ID: 27262692
    [No Abstract]   [Full Text] [Related]  

  • 28. Association between oral metformin use and the risk of age-related macular degeneration: A systematic review with meta-analysis.
    Holtz JK; Thinggaard BS; Grauslund J; Subhi Y
    Acta Ophthalmol; 2023 Sep; 101(6):595-605. PubMed ID: 36876510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is lipoxins A₄ a better alternative to anti-VEGF and anti-TNF-α antibody to prevent and treat age-related macular degeneration, diabetic macular edema and retinopathy?
    Das UN
    Med Sci Monit; 2012 Jan; 18(1):LE1-2. PubMed ID: 22207123
    [No Abstract]   [Full Text] [Related]  

  • 30. Aspirin, iron loss, and age-related macular degeneration.
    Mascitelli L; Pezzetta F; Goldstein MR
    Med Hypotheses; 2010 Apr; 74(4):754-5. PubMed ID: 19969426
    [No Abstract]   [Full Text] [Related]  

  • 31. [Anti-cancer activity of metformin: new perspectives for an old drug].
    Beck E; Scheen AJ
    Rev Med Suisse; 2010 Sep; 6(260):1601-7. PubMed ID: 20853715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatments targeting autophagy ameliorate the age-related macular degeneration phenotype in mice lacking APOE (apolipoprotein E).
    Vessey KA; Jobling AI; Tran MX; Wang AY; Greferath U; Fletcher EL
    Autophagy; 2022 Oct; 18(10):2368-2384. PubMed ID: 35196199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin: a review of its potential indications.
    Wang YW; He SJ; Feng X; Cheng J; Luo YT; Tian L; Huang Q
    Drug Des Devel Ther; 2017; 11():2421-2429. PubMed ID: 28860713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are antioxidants or other supplements protective for age-related macular degeneration?
    Fekrat S; Bressler SB
    Curr Opin Ophthalmol; 1996 Jun; 7(3):65-72. PubMed ID: 10163462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A potential protective effect of metformin in adenoid cystic carcinoma.
    Lancione PJ; Kumar B; Zhao S; Mroz EA; Brock G; Rocco JW; Carrau RL; Agrawal A; Seim N; Kang SY; Ozer E; Old MO
    Oral Oncol; 2020 Aug; 107():104726. PubMed ID: 32388409
    [No Abstract]   [Full Text] [Related]  

  • 36. New treatments for age-related macular degeneration.
    Wagle AM; Yeo TK; Au Eong KG
    Lancet; 2007 Oct; 370(9597):1481. PubMed ID: 17964347
    [No Abstract]   [Full Text] [Related]  

  • 37. Metformin as a protective agent against natural or chemical toxicities: a comprehensive review on drug repositioning.
    Meshkani SE; Mahdian D; Abbaszadeh-Goudarzi K; Abroudi M; Dadashizadeh G; Lalau JD; De Broe ME; Hosseinzadeh H
    J Endocrinol Invest; 2020 Jan; 43(1):1-19. PubMed ID: 31098946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms involved in the protective effects of metformin against nonalcoholic fatty liver disease.
    Barbero-Becerra VJ; Santiago-Hernandez JJ; Villegas-Lopez FA; Mendez-Sanchez N; Uribe M; Chavez-Tapia NC
    Curr Med Chem; 2012; 19(18):2918-23. PubMed ID: 22519397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nutritional supplement use and age-related macular degeneration.
    Chew EY
    Curr Opin Ophthalmol; 1995 Jun; 6(3):19-24. PubMed ID: 10150867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention and treatment of age-related macular degeneration: an update for pharmacists.
    Marshall LL; Roach JM
    Consult Pharm; 2013 Nov; 28(11):723-37. PubMed ID: 24217192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.